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Background: Pigment epithelium-derived factor (PEDF) is a 50-kDa secreted glycoprotein that is highly expressed
in cardiomyocytes. A variety of peptides derived from PEDF exerts diverse physiological activities including
anti-angiogenesis, antivasopermeability, and neurotrophic activities. Recent studies demonstrated that segmental
functional peptides of PEDF, 44mer peptide (Val78–Thr121), show similar neurotrophic and cytoprotective effect to
that of the holoprotein. We found that PEDF can reduce infarct size and protect cardiac function after acute
myocardial infarction (AMI). However, the effects of PEDF on cardiac triglyceride (TG) accumulation after AMI remain
unknown. The present study was performed to demonstrate the influence of PEDF and its functional peptides
44mer on TG degradation in AMI.
Methods: The left ascending coronary artery (LAD) was ligated to induce AMI. PEDF-small interfering RNA
(siRNA)-lentivirus (PEDF-RNAi-LV) or PEDF-LV was delivered to the ischemic myocardium in order to knock down
or overexpress PEDF, respectively. Oil Red O staining and a TG assay kit were used to analyze the TG content in
cardiomyocytes and infarcted areas.
Results: The TG content significantly decreased in the PEDF-overexpressing heart compared to the sham group
(P < 0.05). Both rPEDF and 44mer administration stimulate the TG degradation in cultured cardiomyocytes (P < 0.05).
Adipose triglyceride lipase (ATGL)-specific inhibitor, atglistatin, attenuated the PEDF or 44mer-induced TG lipolysis
activation of cardiomyocytes at 10 μmol/L. The effects of PEDF and 44mer on myocardial TG degradation were also
abolished when ATGL was downregulated.
Conclusions: We conclude that PEDF and 44mer promote TG degradation in cardiomyocytes after AMI via ATGL.
The substitution of PEDF and 44mer may be a novel therapeutic strategy for cardiac TG accumulation after AMI.
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Acute myocardial infarction (AMI) is among the leading
causes of death in western societies. During AMI, re-
duced oxygen availability promotes triglyceride (TG) ac-
cumulation in cardiomyocytes [1]. Fat accumulation is
toxic to cardiomyocytes and plays an important role in
the progression of cardiomyopathy and heart failure [2].* Correspondence: zhang_zhongming@xzmc.edu.cn; dhy@xzmc.edu.cn
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unless otherwise stated.Insulin-sensitizing drugs can reduce the deposition of lipids
in the myocardium and reverse contractile dysfunction in
lipotoxic rats, suggesting that intramyocardial TG accumu-
lation is deleterious [3]. Thus, reducing TG accumulation
in cardiomyo- cytes in the ischemic heart is beneficial.
Pigment epithelium-derived factor (PEDF) is a mem-
ber of the superfamily of serine protease inhibitors and
was first identified in cultured retinal pigment epithelial
cells [4]. It is expressed in many cell types, including adi-
pocytes, hepatic cells and the cells of the eye. It is a
multifunctional, pleiotropic protein with antiangiogenic,
antioxidant, antithrombotic, neurotrophic and neuropro-
tective properties [5,6]. Clinical studies have demon-
strated that the level of plasma PEDF was elevated in anThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Zhang et al. Journal of Translational Medicine  (2015) 13:68 Page 2 of 12obese population [7], as well as in metabolic syndrome
[8] and type 2 diabetes patients [9]. Recent studies dem-
onstrated that PEDF sourced from adipose tissue con-
tributed to enhanced adipocyte lipolysis [10].
PEDF is thought to exert its biologic actions by binding
to a cell surface receptor. A recent report noted that adi-
pose triglyceride lipase (ATGL) is a receptor for PEDF in
retinal epithelial cells and utilized a cell-free system to
demonstrate that this interaction induced lipase activity
[11]. ATGL is the key enzyme of TG catabolism and func-
tions as a monoacyl hydrolase that catalyzes the initial,
rate-limiting step of the TG lipolysis cascade [12]. The ab-
sence of this enzyme in cardiac muscle causes a lipolytic
defect that result in massive lipid accumulation, severe
cardiac dysfunction and premature death [13]. Petra C.
Kienesberger found that the overexpression of ATGL in
cardiomyocytes was sufficient to enhance myocardial TG
hydrolysis, decrease the cardiomyocyte TG content, and
influence cardiac function at baseline as well as during
pathophysiological stress [14].
Recent studies demonstrated that a variety of peptides
derived from PEDF exerts diverse physiological activities
including anti-angiogenesis, vascular permeability resis-
tance, and neuronal protective effect. Among these func-
tional peptides, the 44mer peptide (aa78-121) derived
from the N-terminal edge of PEDF had neurotrophic
activity in retinoblastoma cells and cerebellar granule-
neurons [15].
Our group found that PEDF can reduce the infarct size
and protect cardiac function from ischemic injury. We
also found that PEDF and its functional peptides 44mer
protect cultured H9c2 cells and primary cardiomyocytes
against apoptosis and necroptosis under hypoxic condi-
tions [16]. However, no study to date has focused on the
relationship between TG accumulation and PEDF or its
derived peptide 44mer after AMI.
In the present study, we demonstrated the role of
PEDF and its functional peptides 44mer in TG regula-
tion and their underlying mechanism, which will provide
novel information about the prevention and treatment
of cardiac TG accumulation after AMI.
Methods
Recombinant lentivirus constructs and viral production
A recombinant lentivirus (LV) was prepared as described
previously. PEDF over-expression plasmids and the
RNAi vector PEDF-RNAi-LV of the PEDF gene that pro-
duces PEDF shRNA were successfully constructed and
then successfully packaged by 293 T cells. The concen-
trated titer of the virus suspension was 2 × 1012 Tu/L.
Reagents
Recombinant PEDF(rPEDF) was synthesized by CUSA-
BIO BIOTECH CO. Ltd. Synthetic peptide 44mer wasdesigned from amino acid positions 78–121 (ILLSPLSVA
TAL SALSLGAEQRTESVIHRALYYDLINNPDIHST) of
the rat PEDF sequence (GenBankTM accession number
NM_177927), and prepared by GL Biochem (Shanghai)
Ltd. Atglistatin was purchased from MedKoo Biosciences
(USA). Polyclonal goat anti-ATGL antibody and poly-
clonal rabbit anti-PEDF antibody from Santa Cruz were
used in this study.
Experimental animal
Neonatal Sprague–Dawley (SD) rats (1–3 d old, weigh-
ing 5–7 g) and Male Sprague Dawley rats, 200–250 g,
were purchased from the Experimental Animal Center
of Xuzhou Medical College. All animal experiments
were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication, 8th
Edition, 2011). The animal care and experimental proto-
cols were approved by the Xuzhou Medical College
Committee on Animal Care.
The rats were anesthetized with intraperitoneal injec-
tions of sodium pentobarbital (60 mg/kg, i.p.), and
maintained by bolus injections of sodium pentobarbital
(3–6 mg/kg, i.v.) during anesthesia as required. A left
thoracotomy through the fourth intercostal space was
performed under sterile conditions on a volume-cycled
ventilator SAR-830 (Bio Research Center Inc., Na-goya,
Japan). The left-anterior descending coronary artery
(LAD) was then ligated with a 6–0 silk suture (Ethicon,
Johnson & Johnson, USA) 2 mm distal from its origin.
Sham-operated rats underwent the same procedure, ex-
cluding coronary artery ligation.
For intramyocardial gene delivery, PEDF-LV or PEDF-
RNAi-LV (2 × 107 TU) in 20 μL Enhanced Infection So-
lution (ENIS, pH 7.4) was delivered with a 20-μL syringe
and 25-gauge needle into three sites the myocardium
along the infarct border immediately after surgery. Con-
trol animals received an equivalent volume of lentivirus
vector expressing the green fluorescent protein (GFP)
reporter genes. The validity of myocardial viral vector
transfection was obtained as described previously [17].
Primary cardiomyocyte isolation and cell culture
Ventricular myocytes were isolated from neonatal rats as
previously described [16]. The harvested cells were
plated on glass coverslips in 12-well plates (Corning,
USA) at 1 × 105 cells per well for oil red O and immuno-
fluorescence staining or in 6-well plates (Corning, USA)
for TG contend analysis. More than 90% of the cells
were cardiomyocytes, as evaluated by indirect immu-
nofluorescence staining with a monoclonal anti-actin
(a-sarcomeric) antibody (A2172, Sigma). The cells were
cultured in 5% CO2 at 37°C for 72 h prior to the hypoxia
treatments. Hypoxic conditions were induced by placing
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with a water-saturated atmosphere composed of 5%
CO2/3% O2 for 48 h. All experiments were performed in
accordance with relevant guidelines and regulations.
Oil red O staining
The oil Red O solution was purchased from Sigma-
Aldrich. The cells were washed twice with PBS and fixed
with 4% formaldehyde in PBS for 5 minutes. After three
washes in PBS, the cells were briefly washed with 60%
isopropanol and incubated with 60% filtered oil Red O
solution (0.7 g per 200 ml of isopropanol) for 30 min at
room temperature. The dishes were then rinsed in 60%
isopropanol. To determine cardiac lipid accumulation,
frozen sections of heart (7 μm) were fixed with 4% for-
maldehyde in PBS, stained with oil Red O for 30 minutes
and washed three times. Representative photomicro-
graphs were captured at 200× magnification using a sys-
tem incorporated in the microscope (Olympus, Japan).
Triglyceride assay
The levels of intracellular and heart TGs were assessed
using a TG assay kit (GPO-POD; Applygen Technologies
Inc., Beijing, China) according to the manufacturer’s rec-
ommended protocol. Intracellular free fatty acids were
estimated using an ultrasensitive assay kit for free acids
(Applygen Technologies Inc.) according to the manufac-
turer’s recommended protocol.
Western blot analysis
The cells were washed and scraped with PBS and in-
cubated in an RIPA buffer containing a protease inhibi-
tor cocktail (Roche Diagnostics, Mannheim, Germany).
For the western immunoblot analysis, protein samples
(20 μg/lane) from cardiomyocytes were separated on
10% SDS-PAGE gels and transferred to a nitrocellulose
membrane (Millipore, USA). The membranes were
blocked for 1 h at room temperature with 5% Block-Ace
(DS Pharma Biomedical, Osaka, Japan) in detergent-
supplemented Tris-buffered saline (TBS-T; 20 mm Tris,
150 mm NaCl, 0.05% Tween 20, pH 7.5). The mem-
branes were then incubated with anti-PEDF, anti-β actin
or anti-ATGL antibodies overnight at 4°C, washed in
TBS-T (3 × 10 min), and then incubated with fluores-
cently labeled secondary antibody (Rockland, USA) for
1 h at room temperature. After washing, the protein
bands were scanned by the Odyssey Infrared Imaging
System (Li-Cor Biosciences, USA).
Quantitative qPCR–based gene expression
The total RNA was extracted from tissues or cells using
TRIzol reagent (Invitrogen, Carlsbad, CA) and treated
with RNase-Free DNase. Five hundred nanograms of
total RNA was used for reverse transcription andquantitative real-time PCR analysis (qPCR). Real-time
quantitative PCR was performed on a Light Cycler 480II
(Roche, Switzerland) using SYBR Green PCR Master
Mix (Applied Biosystems). The results were normalized
to the expression of the GAPDH gene. The sequences of
the forward and reverse primer were 5′- CATGGCCTT
CCGTGTTCCTA −3′ and 5′- GCGGCACGTCAGAT
CCA −3′ for the GAPDH gene, 5′- CCAACGCCACT
CACATCTAC −3′ and 5′- AGCAGGCAGGGTCTT
CAGTA −3′ for the ATGL gene, 5’- CCGTAGTG GAG
GAGGATGAC −3′ and 5’- ATCGTAGCCGAAGTTG
GAAAC −3′ for the PEDF gene, 5′- TGACAGGG
TGGCTTCCTAC −3′ and 5′- CGCAC AGGTTCTTT
CTTGTAA −3′ for the CGI-58 gene.
Immunoprecipitation
The cells were lysed in ice-cold buffer [in mmol/L: Mops
(pH 7.4) 50, sucrose 320, KCl 100, MgCl 20.5, and inhi-
bitors of proteases and phosphatases (β-glycerophos-
phate 20, sodium pyrophosphate 20, NaF 50, 1 mmol/L
each of EDTA, EGTA, phenylmethylsulfonyl fluoride,
benzamidine, sodium orthovanadate, and p-nitrophenyl
phosphate, and 5 μg/mL each of aprotinin, leupeptin,
and pepstatin A)]. The cell lysates were pre-cleared with
30 μl of immobilized protein A/G-agarose (Pierce) for
30 min on a rotator at room temperature and then cen-
trifuged at 14,000 g and 4°C for 30 min. Two hundred
and fifty microliters of the pre-cleared supernatant was
incubated overnight at 4°C with appropriate antibo-
dies diluted in immunoprecipitation buffer [in mmol/L:
Hepes 50 (pH 7.4), NaCl 150, glycerol 10% (vol/vol),
ZnCl 21, MgCl 21.5, Triton X-100 1%, Nonidet P-40
0.5%, and the phosphatase and protease inhibitors men-
tioned above]. The mixture was then incubated with
50 μl of protein A-Sepharose CL-4B at 4°C for an add-
itional 2 h. The samples were then washed three times
with cold immunoprecipitation buffer and eluted by
boiling for 5 min in 4 × Laemmli sample buffer. The
samples were separated on 4-12% polyacrylamide
NuPAGE gels (Invitrogen), transferred to nitrocellulose
membranes, and probed with the specific indicated
antibodies, followed by a corresponding horseradish
peroxidase-conjugated secondary antibody.
Double immunofluorescence staining
Double-labeling immunofluorescence was performed to
detect the ATGL and PEDF localization in cardiomyo-
cytes. Cardiomyocytes were cultured on coverslips in tis-
sue culture dishes. After fixation in 4% paraformaldehyde
for 20 min at room temperature, the cells were washed 3
times with PBS (Phosphate Buffered Saline) and blocked
for 30 min. Mouse anti-rat antibodies raised against actin
(a-sarcomeric) (A2172, Sigma) were used as a cardiomyo-
cyte marker protein. Rabbit anti-rat antibodies against
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against ATGL (Santa Cruz, CA, USA) were applied to
cells in different dishes and incubated overnight at 4°C.
After washing, the PEDF- and ATGL-stained cells were
incubated with Alexa Fluor® 594 anti-rabbit antibodies (life
technologies) and Alexa Fluor® 488 rabbit anti-goat anti-
bodies (life technologies), respectively, for 1 h at room
temperature. The nuclei were counterstained with DAPI,
and the cover slips were mounted on slides using 50% gly-
cerin. The stained samples were photographed and ana-
lyzed using the TCS SP8 STED 3X (Leica, Germany).
Electron microscopy
For transmission electron microscopy (TEM) observa-
tion, small samples of heart tissue were fixed in 2.5%
glutaraldehyde overnight and then incubated while pro-
tected from light in 1% osmium tetroxide for 2 hours.
After washing in distilled water, the specimens were in-
cubated in 2% uranyl acetate for 2 hours at room
temperature and then dehydrated in graded ethanol con-
centrations. Finally, the samples were embedded in
molds with fresh resin. Ultrathin sections were obtained
with an EM UC7 (Leica, Germany), stained with lead cit-
rate and examined with a Tecnai G2 T12 (FEI, USA).
Immuno-electron microscope experiment
Double immunocytochemical staining was applied for
the detection of colocalization of PEDF with ATGL at
electron microscopic level. Immuno-electron microscope
experiment was employed based on the method de-
scribed previously [18].
Statistical analysis
The results are expressed as the means ± standard error.
Statistical analysis of the results was carried out using
the Student’s t-test or one-way analysis of the variance
(ANOVA) followed by the Duncan’s new multiple range
method or Newman-Keuls test. P < 0.05 was considered
significant.
Results
Lipid droplets accumulated in ischemic rat heart tissue
and hypoxic cardiomyocytes
Of the 20 rats entered into the present experiment, 4
died within 24 hours of surgery. Thus, 16 rats were
available for morphometric and hemodynamic analyses
and randomized into four groups (n = 5 at 2 weeks, n = 6
at 4 weeks, n = 5 at 6 weeks). As shown above (Figure 1A),
substantial lipid accumulation was observed in the in-
farcted areas of the LV 2, 4 and 6 weeks after AMI,
whereas no accumulation was visible in the normal group.
A biochemical analysis of the muscle TG levels revealed a
1.6-fold increase in the cardiomyocyte TG content in in-
farcted rats 4 week after AMI compared with the normalcontrols (Figure 1B). Freshly isolated rat cardiomyocytes
were incubated in 3% O2, which resulted in the accumula-
tion of intracellular LD as evidenced by bright yellow dots
in the micrographs of oil red O stained cells (Figure 1C).
LDs could not be detected in normoxic cells. Further-
more, most of the cells were identified as cardiomyocytes
because oil red O-positive cells were found to be cardiac
myosin-positive myocytes (Figure 1E). Electron micro-
scope images also showed a marked lipid accumulation in
the borderline and ischaemic tissue 4 week after AMI
compared with the normally perfused tissues (Figure 1F).
Expression of PEDF and ATGL in the rat heart
The protein expression levels in LV after AMI at 2, 4
and 6 weeks were compared to the normal animals. As
shown in Figure 2A, the protein levels of PEDF in the
infarcted areas of LV significantly decreased 2 weeks
after AMI compared with those of the normal group
and remained low during the observational periods.
However, the protein level of ATGL in infarcted areas of
LV began to increase at 2 weeks and reached a max-
imum 4 weeks after LAD artery ligation; the peak value
was 3.5-fold higher than the basal level (Figure 2C).
Moreover, a similar decrease in PEDF transcripts and an
increase in ATGL transcripts were observed in the qPCR
assay in infarcted areas of LV at all time points. The level
of PEDF decreased by 45% in infarcted hearts, whereas
the ATGL levels increased 3-fold 4 weeks after infarction
(Figure 2B and D). ATGL protein levels were signifi-
cantly increased in the infarcted areas of LV compared
to the normal group suggesting that cardiac TG accu-
mulation is apparently controlled by the decrease of
PEDF protein levels.
PEDF and 44mer regulate TG degradation in
cardiomyocytes
PEDF was down regulated in cardiomyocytes after AMI.
Thus, to verify the potential function of PEDF in TG
degradation, we delivered lentivirus carrying PEDF or
PEDF RNAi by using intramyocardial injections to
overexpress or knockdown PEDF in a rat AMI model
(Figure 3A). In the infarcted zone, the myocardial TG
content of the PEDF group was less than those of the
other groups (Figure 3C and D). An examination of the
siPEDF group revealed more fat accumulation in the car-
diomyocytes than in the other groups. Cardiomyocytes
incubated in 3% O2 for 24 hours were fixed with 4%
paraformaldehyde, followed by staining with oil Red O.
In vitro, cardiomyocytes were incubated for 72 h
under normal condition, and then treated with rPEDF
(10nM) or 44mer (10nM) 6 h prior to the hypoxia treat-
ments. We found the rPEDF and 44mer groups showed
fewer and smaller lipid droplets in the cytoplasm than the
hypoxia group (Figure 3E). Accordingly, the quantitation
Figure 1 (See legend on next page.)
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Figure 1 Accumulation of neutral lipids in heart of infarcted rat and hypoxia cardiomyocytes. A: lipid accumulation in the ventricular
muscle from rat 2, 4, and 6 weeks after an experimentally induced myocardial infarction, as shown by oil red O staining (red). B: the TG content
in hearts from rat 2, 4, and 6 weeks after an experimentally induced myocardial infarction. Values are means ± SD of at least 3 hearts. *P < 0.05
compared the normal group. Scale bar, 40 μm. C: lipid accumulation in cardiomyocytes incubated in normoxia condition or hypoxia conditions
for 12, 24 and 48 hours. D: TG content in cardiomyocytes incubated in normoxia condition or hypoxia conditions for 12, 24 and 48 hours. n = 4,
Values are means ± SD. *P < 0.05 compared with normal group. Scale bar, 20 μm. E: oil red O-positive cells were found to be α-sarcomeric actin
positive myocytes. Nucleuses were stained with DAPI (blue). Scale bar, 10 μm. F: representative electron microscopic views of the normally
perfused tissue, borderline tissue and central ischemic tissue from the left ventricular 4 weeks after myocardial infarct induction. Lipid droplets
(arrowheads) are present in borderline and central ischemic tissue. All experiments were carried out three times. Scale bar, 500 nm.
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the rPEDF and 44mer groups were significantly lower than
the hypoxia group (Figure 3F). Figure 3G showed a 20%
and 18% increase in FFA levels with PEDF and 44mer as
compared with hypoxia group (P < 0.05). We also per-
formed the experiment in the absence of hypoxia stress.Figure 2 Expression of PEDF and ATGL in the rat heart. A and C: Expre
Upper panels show representative results of PEDF and ATGL immunostaini
β-actin was used as a loading control. The bands were quantified using the Im
β-actin. n = 3 per group. W indicates weeks. Values are means ± SD. *P < 0.05
in infarcted area 2, 4 and 6 weeks after infarction by qPCR analysis. NADPH w
compared with normal group.We found that the TG content is significantly lower under
normal culture conditions in cardiomyocytes that
expressed less PEDF than in wild-type cardiomyocytes.
Treating wild-type cardiomyocytes with rPEDF or 44mer
did not significantly affect the TG degradation in cultured
cardiomyocytes, while PEDF downregulation significantlyssion of PEDF and ATGL protein 2, 4 and 6 weeks after infarction.
ng. Lower panels show the quantitative data of PEDF and ATGL.
age J software, and the data were transformed and normalized to
compared with normal group. B and D: PEDF and ATGL mRNA expression
as used as an internal control. n = 4, Values are means ± SD. *P < 0.05
Figure 3 (See legend on next page.)
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Figure 3 PEDF and 44mer regulate TG degradation in cardiomyocytes. A: western blot determination for PEDF protein expression in a rat
AMI model. B: densitometry of the western blots shown in (A), normalized to β-actin. n = 3, values are means ± SD. *P < 0.05 compared with
normal group. **P < 0.05 compared with normal group and PEDF group. C: intracellular lipids were stained with oil Red O 4 weeks after AMI. The
siPEDF group showed an abundance of lipid droplets, whereas the PEDF group showed very little staining. Scale bar, 40 μm. D: quantification of
the lipid content in the heart on 4 weeks after AMI by biochemical methods. n = 3, values are means ± SD. *P < 0.05 compared with normal
group; **P < 0.05 compared with vector group. #P < 0.05 compared with vector group and siPEDF group. E: the intracellular lipids were stained
with oil Red O after 1 day of hypoxia. The hypoxia group showed an abundance of lipid droplets, whereas the rPEDF (10 nM) and 44mer (10 nM)
groups showed very little staining. Scale bar, 20 μm. F: quantification of lipid content in cardiomyocytes after 1 day of hypoxia by biochemical
methods. n = 3, values are means ± SD. *P < 0.05 compared with normal group; #P < 0.05 compared with hypoxia group. G: Influence of PEDF and
44mer on intracellular FFA under hypoxia condition. Values are means ± SD. *P < 0.05 compared with hypoxia group. H: PEDF downregulation in
cardiomyocytes significantly increased the TG content compared to wild-type cardiomyocytes. The TG content did not significantly change in WT
cardiomyocytes treated with rPEDF or 44mer, while the addition of rPEDF or 44mer to cardiomyocytes that expressed less PEDF significantly
decreased the TG content. n = 3, values are means ± SD. *P < 0.05 compared with control group; #P < 0.05 compared with siPEDF group.
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Taken together, our data suggest that PEDF and 44mer
stimulate cardiac TG degradation.
PEDF or 44mer on TG degradation was not due to
increases in the expression of ATGL and CGI-58
ATGL was identified as a rate-limiting TG lipase, and its
activity is stimulated by comparative gene identification-
58 (CGI-58). Some studies have indicated that increased
ATGL and CGI-58 expression could decrease the TG
content. To determine whether the effect of PEDF or
44mer on TG degradation was due to increased ATGL
and CGI-58 expression, the ATGL and CGI-58 mRNAFigure 4 Effects of PEDF and 44mer on ATGL and CGI-58 mRNA in ca
expression, samples treated with rPEDF or 44mer. B: densitometry of the w
means ± SD. *P < 0.05 compared with control group. C: PEDF administration
*P < 0.05 compared with control group. D: PEDF and 44mer did not affect thlevels were evaluated using qPCR. ATGL protein levels
were not increased in the PEDF and 44mer groups com-
pared to the control group (Figure 4A and B) suggesting
that PEDF and 44mer function in the regulation of car-
diac TG degradation was not apparently controlled by
changes in ATGL protein expression levels. Further-
more, we used qPCR analysis to identify changes in the
levels of ATGL mRNA. As shown in Figure 4C, rPEDF
administration decreased the ATGL mRNA level while
44mer had no effect on the expression of ATGL. rPEDF
or 44mer treatment did not change the level of CGI-58
mRNA compared to the control group (Figure 4D).
These results indicated that the effect of PEDF or 44merrdiomyocytes. A: western blot determination for ATGL protein
estern blots shown in (A), normalized to β-actin. n = 3, values are
caused the ATGL mRNA levels to decrease. n = 5, values are means ± SD.
e expression of CGI-58 mRNA. n = 5, values are means ± SD.
Figure 5 ATGL and PEDF co-localize with lipid droplets in cardiomyocytes. A: cardiomyocyte lysates were immunoprecipitated with ATGL
or PEDF antibody, and the lysates were then detected with PEDF or ATGL antibodies. B: co-localization of PEDF (green) and ATGL (red) assessed
via the double immunofluorescent labeling of cardiomyocytes. Yellow color indicates the merging of green and red. Scale bar, 2 μm. C: immunoelectron
microscopy images showed that PEDF (labeled with gold particles of 5 nm in diameter) and ATGL (labeled with gold particles of 10 nm in diameter)
co-localized around the lipid droplet and that the spatial distance between PEDF and ATGL was less than 20 nm. Scale bar, 100 nm.
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pression of ATGL and CGI-58.
ATGL and PEDF co-localize to lipid droplets
A precipitate analysis indicated that full-length PEDF co-
immunoprecipitated with full-length ATGL (Figure 5A)
when anti-PEDF antibody was used, indicating a
direct interaction between PEDF and ATGL. The co-
immunoprecipitation experiment with anti-ATGL anti-
bodies also co-immunoprecipitated ATGL and PEDF. To
test whether ATGL and PEDF traffic to the lipid droplet
in cardiomyocytes, the localization of PEDF and ATGL in
rat primary cardiomyocytes was assessed using stimu-
lated emission depletion (STED) microscopy imaging. As
shown in Figure 5B, we found that PEDF co-localized with
ATGL in the same discrete circular rings identified as lipid
droplets by oil red O staining. An immuno-electron
microscope experiment was also performed to evaluate
the binding between endogenous PEDF and ATGL in car-
diomyocytes. This experiment showed that PEDF and
ATGL co-localize around the lipid droplet and that the
spatial distance between PEDF and ATGL was less than
20 nm (Figure 5C).
PEDF and 44mer-induced TG degradation depend on the
ATGL lipolysis activity
To test whether ATGL is required for PEDF or 44mer
TG degradation, we used siRNA to knock down the
endogenous ATGL expression in cardiomyocytes. As
shown in Figure 6A, a band near 55 kDa was observed
in the ATGL overexpression group, whereas the band
was less pronounced in the siATGL group than in thecontrol. rPEDF and 44mer administration into car-
diomyocytes medium decreased the TG content when
ATGL was overexpressed; however, these effects were
abolished when ATGL was downregulated (Figure 6C
and D). The necessity of the lipolysis activity of ATGL
for PEDF and 44mer-mediated TG degradation was fur-
ther confirmed by culturing cardiomyocytes with an
ATGL-specific inhibitor, atglistatin, prior to the addition
of PEDF and 44mer. Atglistatin attenuated the PEDF
and 44mer-induced TG lipolysis activation of cardio-
myocytes at 10 μmol/L. (Figure 6E). These results sug-
gest that PEDF and 44mer-induced TG degradation
depend on ATGL.
Discussion
PEDF is a multifunctional, pleiotropic protein with anti-
oxidant and antithrombotic properties. It is strongly
expressed in the heart and linked to atherosclerosis [19].
Our group found that PEDF can improve functional re-
covery in an AMI rat model. However, the reason for
this improvement was poorly understood. In this article,
we demonstrated the importance of PEDF and its func-
tional peptides 44mer in hypoxia/ischemia-induced lipid
accumulation in cardiomyocytes, and we also demon-
strated the importance of the PEDF-ATGL interaction in
regulating the TG content of the rat heart. PEDF and
44mer may improve cardiac function after infarction via
these mechanisms.
Under normal physiologic conditions, the heart utilizes
fatty acids as its chief energy substrate. Because the cap-
acity for TG storage in the cardiomyocyte is limited, the
uptake and oxidation of fatty acids is tightly coupled
Figure 6 PEDF and 44mer-induced TG degradation depend on the ATGL lipolysis activity. A: western blots for ATGL of untreated control
cell samples, samples treated with ATGL overexpression, and samples treated with ATGL siRNA compared with β-actin are shown. B: densitometry
of the western blots shown in (A) normalized to β-actin. n = 3, values are means ± SD. *P < 0.05 compared with control samples. **P < 0.05 compared
with control samples and ATGL group. C: oil red O staining of untreated control cardiomyocytes, cardiomyocytes treated with siATGL + rPEDF,
cardiomyocytes treated with siATGL + 44mer, cardiomyocytes treated with ATGL + rPEDF and cardiomyocytes treated with ATGL + 44mer. Scale bar,
20 μm. D: quantification of TG content of cardiomyocytes samples shown in (A), *P < 0.05 compared with control group. n = 3, Values are means ± SD.
E: quantification of TG content in the presence of ATGL inhibitor atglistatin. n = 4, *P < 0.05 compared with control group; #P < 0.05 compared with
hypoxia group. Values are means ± SD.
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mia, the heart switches the primary energy source to
glucose instead of fatty acids to conserve oxygen during
ATP generation [21]. If the supply of FFAs exceeds the
capacity for FAO, the excess FFAs are incorporated into
TG, which results in cardiac steatosis. Excess lipid accu-
mulation in the heart has been shown to manifest as
“cardiac lipotoxicity”, which leads to cardiac myocyte
apoptosis and subsequent contractile dysfunction [22].
Bilheimer et al. showed that the most pronounced accu-
mulation of labeled lipids after 6 to 24 h of LAD occlu-
sion was located in the tissue surrounding the ischemic
myocardium [23]. In this study, histological analyses ofthe infarcted hearts showed that lipid droplets continued
to accumulate within cardiac myocytes 2, 4 and 6 weeks
after myocardial ischemia. We also showed that the expres-
sion of PEDF dramatically decreased in biopsies from the
left ventricle of ischemic rat hearts compared with biopsies
from nonischemic left ventricles, which is consistent with
the studies that PEDF is down-regulated in human cardiac
myocytes and human cardiac fibroblasts by anoxia [24].
These findings indicate that PEDF may play an important
role in preventing lipid accumulation in the ischemic heart.
Therefore, in this study, we focused our attention on over-
expressing PEDF in vivo and in vitro in order to investigate
the effects and elucidate possible mechanisms.
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gent and cell type-specific. Early studies clearly demon-
strated a pro-survival function in neuronal cells [25]
whereas subsequent reports showed that PEDF can pro-
mote the apoptosis of activated endothelial cells [26]. As
a secreted glycoprotein, the binding of PEDF to its re-
ceptor is the first step that mediates its biological effects.
A 55-kDa phospholipase-linked membrane protein, the
independent phospholipase A2 (PLA2)/adipose triglycer-
ide lipase (ATGL), has been identified as a PEDF recep-
tor [11]. ATGL is a specific TG hydrolase. It plays a
critical role in the degradation of TG stored in intracel-
lular lipid droplets [12,27] and possesses TG lipase and
acylglycerol transacylase activities in adipose systems. In
humans, mutations in the ATGL gene (PNPLA2) are
associated with a rare inherited disorder annotated as
neutral lipid storage disease with myopathy (NLSD-M)
[28]. To date, most of published experimental work has
focused on the role of ATGL in this process. In ATGL-ko
mice, the excess accumulation of TGs in the heart causes
cardiac abnormalities, and these mice suffer from prema-
ture death due to severe cardiac steatosis and dysfunction
[29,30]. However, the exact role of PEDF in the process of
TG degradation after myocardial infarction remains
poorly understood. Our results showed that the TG con-
tent was higher in siPEDF rats than in PEDF-overexpress-
ing rats after myocardial infarction. Both rPEDF and
44mer administration stimulate the TG degradation in
cultured cardiomyocytes. Thus, our results indicated that
PEDF and 44mer have an important effect on the degrad-
ation of TGs in cardiomyocytes and that the decreased ex-
pression of PEDF is essential for the accumulation of TGs
in hypoxic cardiomyocytes and the ischemic myocardium
in rats. However, PEDF and 44mer could not directly pro-
mote the metabolism of TGs. After decreasing the level of
ATGL, the corresponding variations began to disappear.
These results conclusively demonstrated that the PEDF
and 44mer can stimulate ATGL activity.
Chung et al. showed that PEDF regulates the hepato-
cyte TG content by binding to ATGL on lipid droplets
[31]. But, it was still uncertain whether PEDF and 44mer
have directly affects on ATGL in cardiomyocytes. Cer-
tain proteins regulate the ATGL enzyme activity. CGI-58
(comparative gene expression protein-58, also known as
hydrolase domain containing protein 5, ABHD5) func-
tions as an activator protein of ATGL and exhibits no
intrinsic TG hydrolase activity [32]. ATGL activity pri-
marily increases under acute lipolytic stimulation via
interaction with CGI-58. By detecting the expression
levels of CGI-58 and ATGL, we found that PEDF and
44mer did not increase the expression of CGI-58 or
ATGL. Moreover, we provided evidence in cardiomyo-
cytes to suggest that PEDF and ATGL co-localized in a
pattern consistent with lipid droplets. We also observedby immunoelectron microscopy that the spatial distance
between PEDF and ATGL is less than 20 nm. This
phenomenon indicated that the interaction between PEDF
and ATGL was direct. Thus, we speculated that PEDF
stimulates ATGL lipase activity by linking itself to ATGL.
Conclusions
In summary and to the best of our knowledge, this study
is the first to show that PEDF down-regulation contri-
butes to the defect of ATGL transacylase activity, which
subsequently leads to TG storage in cardiomyocytes in
hypoxic conditions. PEDF and its functional peptides
44mer may offer a novel promising strategy for the treat-
ment of myocardial TG accumulation after AMI. Yet,
some studies indicated the increased ectopic lipid stor-
age per se does not cause lipotoxicity [33]. But, the
lipolysis of TGs to free FAs enables the production of
ATP in the mitochondria via β-oxidation. PEDF may also
exert survival actions in the cardiomyocytes via a lipid-
signaling pathway mediated by ATGL. However, the de-
tailed products of TG degradation remain unknown.
Therefore, future investigations are needed to clarify the
species of FFAs by which PEDF and 44mer protect car-
diac function from ischemic injury.
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